2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older diagnosed with epithelial ovarian,Continue reading “2025 #507 MIPS Measure Appropriate Germline Testing for Ovarian Cancer Patients”
CQMS Archive
2025 #506 MIPS Measure Positive PD-L1 Biomarker Expression Test Result Prior to First-Line Immune Checkpoint Inhibitor Therapy
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percentage of patients aged 18 years and older withContinue reading “2025 #506 MIPS Measure Positive PD-L1 Biomarker Expression Test Result Prior to First-Line Immune Checkpoint Inhibitor Therapy”
2025 #505 MIPS Measure Reduction in Suicidal Ideation or Behavior Symptoms
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure (PRO-PM) – High Priority Description: The percentage of patients agedContinue reading “2025 #505 MIPS Measure Reduction in Suicidal Ideation or Behavior Symptoms”
2025 #504 MIPS Measure Initiation, Review, and/or Update to Suicide Safety Plan for Individuals with Suicidal Thoughts, Behavior, or Suicide Risk
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percentage of patients aged 12 years and older withContinue reading “2025 #504 MIPS Measure Initiation, Review, and/or Update to Suicide Safety Plan for Individuals with Suicidal Thoughts, Behavior, or Suicide Risk”
2025 #503 MIPS Measure Gains in Patient Activation Measure (PAM) Scores at 12 Months
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Measure (PRO-PM) – High Priority Description: The Patient Activation Measure® (PAM®) isContinue reading “2025 #503 MIPS Measure Gains in Patient Activation Measure (PAM) Scores at 12 Months”
2025 #502 MIPS Measure Improvement or Maintenance of Functioning for Individuals with a Mental and/or Substance Use Disorder
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient-Reported Outcome-based Performance Measure (PRO-PM) – High Priority Description: The percentage of patients agedContinue reading “2025 #502 MIPS Measure Improvement or Maintenance of Functioning for Individuals with a Mental and/or Substance Use Disorder”
2025 #501 MIPS Measure Acute Posterior Vitreous Detachment and Acute Vitreous Hemorrhage Appropriate Examination and Follow-up
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients with a diagnosis of acute posterior vitreous detachment (PVD)Continue reading “2025 #501 MIPS Measure Acute Posterior Vitreous Detachment and Acute Vitreous Hemorrhage Appropriate Examination and Follow-up”
2025 #500 MIPS Measure Acute Posterior Vitreous Detachment Appropriate Examination and Follow-up
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients with a diagnosis of acute posterior vitreous detachment (PVD)Continue reading “2025 #500 MIPS Measure Acute Posterior Vitreous Detachment Appropriate Examination and Follow-up”
2025 #499 MIPS Measure Appropriate Screening and Plan of Care for Elevated Intraocular Pressure Following Intravitreal or Periocular Steroid Therapy
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients who had an intravitreal or periocular corticosteroid injection (e.g.,Continue reading “2025 #499 MIPS Measure Appropriate Screening and Plan of Care for Elevated Intraocular Pressure Following Intravitreal or Periocular Steroid Therapy”
2025 #498 MIPS Measure Connection to Community Service Provider
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percent of patients 18 years or older who screenContinue reading “2025 #498 MIPS Measure Connection to Community Service Provider”